表紙
市場調査レポート

世界の性感染症(STD)市場の展望・新しい機会

2016-2020 World Sexually-Transmitted Disease (STD) Diagnostics Market--Supplier Shares, Country Segment Volume and Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review

発行 Venture Planning Group 商品コード 323064
出版日 ページ情報 英文 350 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。

Local License: 同一事業所内

Back to Top
世界の性感染症(STD)市場の展望・新しい機会 2016-2020 World Sexually-Transmitted Disease (STD) Diagnostics Market--Supplier Shares, Country Segment Volume and Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
出版日: ページ情報: 英文 350 Pages
概要

当レポートでは、米国、欧州主要5カ国(フランス、ドイツ、イタリア、スペイン、英国)および日本の性感染症市場について取り上げ、国・市場セグメント別の検査数・売上予測などを提供しています。

第1章 イントロダクション

第2章 世界市場および技術概要

  • 主な感染症検査
    • 軟性下疳
      • 背景
      • 診断検査
      • ワクチンおよび薬剤
    • クラミジア
    • 淋病
    • 単純ヘルペスウイルス
    • ヒトヘルペスウィルス6(HHV-6)
    • パピローマウイルス(HPV)
    • 梅毒
  • 市販されている主要アナライザーの装置レビュー:Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac およびその他のサプライヤー
  • 新興の診断技術
    • 分子診断
    • モノクローナル抗体
    • 免疫測定法
    • 動的光散乱法(DLS)
    • IT
    • 人工知能
    • リポソーム
    • フローサイトメトリー
    • クロマトグラフィー
    • 診断画像
    • ゲルマイクロドロップ(GMD)
    • その他

第3章 フランス:市場規模、成長および主要サプライヤーの売り上げおよび市場シェア

第4章 ドイツ:市場規模、成長および主要サプライヤーの売り上げおよび市場シェア

第5章 イタリア:市場規模、成長および主要サプライヤーの売り上げおよび市場シェア

第6章 日本:市場規模、成長および主要サプライヤーの売り上げおよび市場シェア

第7章 スペイン:市場規模、成長および主要サプライヤーの売り上げおよび市場シェア

第8章 英国:市場規模、成長および主要サプライヤーの売り上げおよび市場シェア

第9章 米国:市場規模、成長および主要サプライヤーの売り上げおよび市場シェア

代替の市場浸透戦略

  • 自社開発
  • 提携契約
  • 大学との契約
  • 非集中的検査市場の流通戦略
    • マーケティングアプローチ
    • 製品の複雑性
    • 顧客嗜好
    • 既存サプライヤー
    • 新興サプライヤー
    • 主な流通業者のタイプ
    • 市場区分

潜在的な市場参入障壁およびリスク

  • 市場の成熟
  • コスト上の制約
  • 競合
  • 技術力および限界
  • 特許保護
  • 規制上の制約
  • 非集中的検査市場の課題

競合評価

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Enzo Biochem
  • 富士レビオ
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • タカラバイオ
  • Thermo Fisher
  • Wallac
  • 和光純薬工業
  • 性感染症
  • 世界市場の展望・機会

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPID16399

About this Report

This report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales forecasts by country and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used
        for STD testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies,
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains: 350 pages and 90 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

  • A. Major Infectious Disease Tests
    • 1. Chancroid
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 2. Chlamydia
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 3. Gonorrhea
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 4. Herpes Simplex Virus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • Human Herpes Virus-6 (HHV-6)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 5. Papillomavirus (HPV)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 6. Syphilis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
  • B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
  • C. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares

V. Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares

VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares

VII. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares

VIII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares

IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac
  • Wako
  • Sexually-Transmitted Diseases
  • Global Market Outlook and Opportunities

List of Tables

  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Pap Smear/HPV Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • France
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Chlamydia Diagnostics Sales by Major Supplier
  • France
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • France
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • France
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • Germany
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • Germany
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • Germany
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • Italy
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Chlamydia Diagnostics Sales by Major Supplier
  • Japan
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • Japan
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • Japan
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • Spain
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Chlamydia Diagnostics Sales by Major Supplier
  • Spain
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • Spain
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.K.
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.K.
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.K.
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chancroid Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chlamydia Diagnostics Sales by Major Supplier
  • U.S.A.
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
Back to Top